Evidence map›Paper›PMID 32090657›Full record

ReviewThe Journal of international medical research2020

The regulation of nitric oxide in tumor progression and therapy.

Ya Hu, Jing Xiang, Linlin Su, Xi Tang

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. NO: a key player in microbiome dynamics and cancer pathogenesis.Frontiers in cellular and infection microbiology · 2025
    Review
  17. Review
  18. Nitric Oxide Signaling and Sensing in Age-Related Diseases.Antioxidants (Basel, Switzerland) · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ya HuDepartment of Pharmacology, Health Science Center, Yangtze University, Jingzhou, Hubei, P. R. China.
Jing XiangCollege of Chemistry & Environmental Engineering, Yangtze University, Jingzhou, Hubei, P. R. China.
Linlin SuDepartment of Burns and Cutaneous Surgery, Xijing Hospital, the Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Xi TangDepartment of Oncology, Jingzhou Central Hospital, Jingzhou, Hubei, P. R. China.ORCID https://orcid.org/0000-0002-9075-0555
Yangtze University · CNJingzhou Central Hospital · CNXijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsCarcinogenesisDisease ProgressionEpigenesis, GeneticGene Expression Regulation, NeoplasticGenetic TherapyHumansNeoplasmsNitric OxideNitric Oxide DonorsNitric Oxide Synthase Type IINitric Oxide Synthase Type IIISignal TransductionTime FactorsAntineoplastic AgentsNitric OxideNitric Oxide DonorsNitric Oxide Synthase Type IINitric Oxide Synthase Type IIINOS2 protein, humanNOS3 protein, humancancerNitric oxidenitric oxide synthasesignalingtumortumor therapy

Identifiers

PMID32090657
PMCPMC7110915
OpenAlexW3008478938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.